Company intelligence / Profile preview

Vermed

United States

Ownership: Private
Development stage: Other

Overview

Vermed offers a comprehensive portfolio of diagnostic and therapeutic single-use medical device consumables—primarily ECG electrodes and chart papers—marketed for hospital patient monitoring, surgical, and pain management applications. Their products are fully commercialized and distributed globally under their own and partner brands. No evidence was found of Vermed engaging in small molecule, biologic, or biotechnology drug discovery/development; the company exclusively produces medical device consumables.

Modalities: Device
Industry: Consumable Medical Devices

Beyond the preview

Go deeper on Vermed.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Vermed.

Explore the full profile